Compare TRIP & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRIP | TXG |
|---|---|---|
| Founded | 2000 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2011 | 2019 |
| Metric | TRIP | TXG |
|---|---|---|
| Price | $15.19 | $15.47 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 10 | 13 |
| Target Price | ★ $15.88 | $14.96 |
| AVG Volume (30 Days) | 2.1M | ★ 2.7M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 124.53 | N/A |
| EPS | ★ 0.59 | N/A |
| Revenue | ★ $1,891,000,000.00 | $641,814,000.00 |
| Revenue This Year | $5.18 | $4.50 |
| Revenue Next Year | $5.08 | N/A |
| P/E Ratio | $25.90 | ★ N/A |
| Revenue Growth | ★ 4.25 | 1.92 |
| 52 Week Low | $10.43 | $6.78 |
| 52 Week High | $20.16 | $20.34 |
| Indicator | TRIP | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 49.86 | 42.37 |
| Support Level | $14.89 | $17.32 |
| Resistance Level | $15.73 | $18.38 |
| Average True Range (ATR) | 0.49 | 0.93 |
| MACD | 0.08 | -0.48 |
| Stochastic Oscillator | 56.02 | 6.01 |
Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, restaurants, experiences, airlines, and cruises. In 2024, 52% of revenue came from the company's core Brand Tripadvisor segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 46% of sales in 2024, and TheFork, its dining brand, represented 10% of revenue (about 8% of sales were intersegment, which are eliminated from consolidated revenue).
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).